WHWK
Whitehawk Therapeutics, Inc.
NASDAQ: WHWK · HEALTHCARE · BIOTECHNOLOGY
$4.04
-2.18% today
Updated 2026-04-29
Market cap
$194.92M
P/E ratio
—
P/S ratio
27.28x
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Whitehawk Therapeutics, Inc. (WHWK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.58M | $-12.70M | $-22.42M | $-49.64M | $-59.66M | $-59.55M | $-97.43M |
| Capital expenditures | $35712.00 | $0.00 | $46000.00 | $444000.00 | $3.97M | $1.65M | $552000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $106142.00 | $139000.00 | $2.11M | $9.64M | $11.95M | $10.84M | $9.87M |
| Free cash flow | $-7.62M | $-12.70M | $-22.47M | $-50.08M | $-63.63M | $-61.20M | $-97.98M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $4.41M | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |